drugset / Trial / NCT01159132
Pharmacokinetics of Low Dose Raltegravir
Phase 2
Completed
24 enrolled
The HIV Netherlands Australia Thailand Research Collaboration
Chulalongkorn University · collabNational Healthcare Group Pte Ltd, Singapore · collab
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to study and compare the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Raltegravir | Other / unclassified | 400 mg | — |
| Comparator | Raltegravir | Other / unclassified | 800 mg | — |